Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glaucoma.

A L Coleman1

  • 1Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles 90095, USA. coleman@jsei.ucla.edu

Lancet (London, England)
|November 30, 1999
PubMed
Summary
This summary is machine-generated.

Glaucoma affects millions globally, causing irreversible blindness. Early detection is crucial for managing this treatable optic nerve disease and preventing vision loss.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The structure of liquid carbon elucidated by in situ X-ray diffraction.

Nature·2025
Same author

Measurements of K-edge and L-edge extended x-ray absorption fine structure at the national ignition facility (invited).

The Review of scientific instruments·2024
Same author

Phase transition kinetics of superionic H<sub>2</sub>O ice phases revealed by Megahertz X-ray free-electron laser-heating experiments.

Nature communications·2024
Same author

Novel experimental setup for megahertz X-ray diffraction in a diamond anvil cell at the High Energy Density (HED) instrument of the European X-ray Free-Electron Laser (EuXFEL).

Journal of synchrotron radiation·2021
Same author

Measurement of Body-Centered Cubic Gold and Melting under Shock Compression.

Physical review letters·2019
Same author

Identification of Phase Transitions and Metastability in Dynamically Compressed Antimony Using Ultrafast X-Ray Diffraction.

Physical review letters·2019
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Public Health

Background:

  • Glaucoma affects an estimated 66.8 million people worldwide, with 6.7 million expected to be bilaterally blind by 2000.
  • Despite public education, diagnosis rates remain low, even in developed nations, leaving many undiagnosed.
  • Visual impairment from glaucoma significantly impacts daily activities like driving and social interaction.

Purpose of the Study:

  • To highlight the critical importance of early glaucoma detection.
  • To underscore that glaucoma, while treatable, causes irreversible vision loss.
  • To emphasize the need for timely diagnosis and management.

Main Methods:

  • Diagnosis relies on optic disc examination and visual field assessment, not solely on eye pressure levels.
  • Distinguishes between primary open-angle glaucoma and primary angle-closure glaucoma, noting different risk factors.

Related Experiment Videos

  • Reviews treatment approaches, acknowledging that patient management differs despite similar medication options.

    • Main Results:

    • A 1998 randomized clinical trial demonstrated the benefit of lowering intraocular pressure (IOP) in glaucoma patients with IOPs of 24 mm Hg or less.
    • This trial provided evidence for the effectiveness of medical or surgical interventions in managing glaucoma.
    • Highlights that effective treatments exist for glaucoma, reinforcing the importance of early intervention.

    Conclusions:

    • Early detection of glaucoma is paramount due to its treatable nature and the irreversible nature of vision impairment.
    • Timely diagnosis and management can prevent or slow disease progression and preserve vision.
    • Continued efforts in public education and screening are essential to improve diagnosis rates and reduce the global burden of glaucoma-related blindness.